Catalyst Wire Dossier Catalyst Wire Dossier

ITOVEBI

INAVOLISIB · Genentech, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ITOVEBI, covering 2024-10-10 to 2026-04-15. Get the full timeline:

Most recent: FDA Approved: ITOVEBI — Supplemental Application (Genentech, Inc.)

See pricing